Study on Gelatin/Hydroxyapatite/Chitosan Material Modified with Osteoblast for Bone Bioengineering

Designing of a suitable ‘cell-material’ construct has enabled the regeneration of bone. It was in accordance with the increasing demand for the repair of defective and/or diseased bone tissue. In this research, the relative behavior of the osteoblast-seeded materials was demonstrated. It enabled the selection of the cell-material system for rabbit bone bioengineering studies. Significant role of polypeptide-polymer-ceramic-cell material in bone tissue engineering was shown. The properties of natural polymer-based scaffold were attributed to their origin and chemical modifications. In this study, the lyophilized osteoblast-material conjugate was designed and characterized extensively. The same was done by physicochemical measurement, for surface and core morphology analysis. The atomic force microscopy (AFM) and transmission electron microscopy (TEM) data from these conjugates have shown surface parameters. The surface suitable for cell attachment and proliferation along with uniform interconnected porous morphology was selected. The calcium to phosphate proportion-based energy-dispersive X-ray was done. It defines the inorganic content in these composites. The crystal spots were found from the selected area electron diffraction pattern. It had supported the insights from the physicochemical measurements. AFM and TEM micrographs have shown surface and core morphology with median surface roughness of 14.96 nm and uniform porous architecture, respectively. Fourier transmission Infra-red spectroscopy and X-ray diffraction had confirmed the formation of mineral deposits within the scaffolds. The subsequent in vitro study has revealed that among the biomaterials, ‘gelatin in hydroxyapatite-coated chitosan matrix’ has prominence over ‘gelatin-hydroxyapatite.’ It was confirmed only after seeding them with the rabbit ‘iliac crest-derived’ osteoblast. Two types of rabbit osteoblast derivatives were used. They are the osteoblast from the bone tissue (rT) and osteoblast obtained after Mesenchymal stem cell (MSCs) differentiation. Bone marrow was the source of MSCs. This ‘rT-seeded’ biomaterial was found appropriate for bone bioengineering applications.